$40m financing to expand AI-powered platform for clinical trials: Saama

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/lovelyday1)
(Image: Getty/lovelyday1)
The clinical data analytics platform firm has raised $75m since 2015 and will continue to enhance both the platform and applications with new capabilities, says CEO.

Saama Technologies today announced that it has closed a $40m financing with Perceptive Advisors, a NY-based firm that focuses on supporting the life sciences industry.

Saama CEO Suresh Katta said the new funding will be used to further invest in and expand the company’s Life Science Analytics Cloud (LSAC).

The platform is powered by artificial intelligence (AI) to support clinical trial design and conduct across various development stages, according to the company.

The new financing – bringing the total Saama has raised since 2015 to $75m – also will help strengthen the company’s commercial team and build its “ecosystem of pharma partners, academia, data providers, and CROs to maximize LSAC utilization and build a suite of collective innovations,”​ Katta told us.

“Saama will continue to enhance both the platform and applications with new capabilities,” ​he added, noting recently examples including three new machine learning-based capabilities that extend the existing functionality of LSAC.

The new virtual assistant, operational and financial risk mitigation, and drug efficacy and patient safety analytics capabilities were released​ during the 10th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando, FL.

Katta said, “Saama is applying Moore's Law to pharma to bring about transformative impact in life sciences by bending the cost and time curve down by applying ruthless amounts of technology to the entire ecosystem of vendors in the drug development process.”

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars